Spruce BiosciencesSPRB
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 32 institutions reported holding Spruce Biosciences Inc. (SPRB) in their 13F filings, unchanged from Q4 2025. 7 opened new positions and 9 sold out. The largest holders were Ikarian Capital, LLC ($7.9M), Millennium Management ($7.3M) and Citadel Advisors ($4.6M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Spruce Biosciences Inc.
- CUSIP
- 85209E208
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $9.0M |
| Exits | 9 | $7.4M |
All 13F filers, Q4 2025 → Q1 2026: 143,255 shares bought and 163,775 shares sold, net −20,520 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Ikarian Capital, LLC | 1.13% | No change | 121,356 | $7.9M |
| Millennium Management | 0.01% | New | 111,888 | $7.3M |
| Citadel Advisors | 0.00% | No change | 69,999 | $4.6M |
| ADAR1 Capital Management, LLC | 0.23% | Add +1.0% | 58,600 | $3.8M |
| Alyeska Investment Group, L.P. | 0.01% | No change | 51,671 | $3.4M |
| Wellington Management Group LLP | 0.00% | Reduce -17.2% | 48,796 | $3.2M |
| Boothbay Fund Management, LLC | 0.07% | Reduce -12.2% | 42,080 | $2.7M |
| Balyasny Asset Management L.P. | 0.01% | No change | 40,000 | $2.6M |
| Carlyle Group Inc. | 0.02% | No change | 38,620 | $2.5M |
| Quinn Opportunity Partners LLC | 0.09% | Add +17.5% | 26,810 | $1.8M |
| ExodusPoint Capital Management, LP | 0.01% | Reduce -12.9% | 22,000 | $1.4M |
| Vanguard Capital Management LLC | 0.00% | — | 18,337 | $1.2M |
| BlackRock, Inc. | 0.00% | No change | 16,938 | $1.1M |
| Geode Capital Management, LLC | 0.00% | Add +1.2% | 12,889 | $843K |
| Squadron Capital Management LLC | 0.32% | Reduce -82.6% | 12,200 | $797K |
| Diadema Partners LP | 0.27% | New | 10,000 | $654K |
| Stempoint Capital LP | 0.08% | New | 6,360 | $416K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 5,514 | $360K |
| Goldman Sachs Group Inc. | 0.00% | New | 5,506 | $360K |
| State Street Corp. | 0.00% | Reduce -15.6% | 5,400 | $353K |
| Resolute Capital Asset Partners LLC | 0.14% | No change | 4,000 | $261K |
| UBS Group AG | 0.00% | Reduce -20.1% | 3,919 | $256K |
| Persistent Asset Partners Ltd | 0.06% | New | 2,528 | $165K |
| Morgan Stanley | 0.00% | Add +264.7% | 1,415 | $92K |
| Lion Point Capital, LP | 0.39% | No change | 1,000 | $65K |
| Citigroup Inc. | 0.00% | New | 939 | $61K |
| Vanguard Global Advisers, LLC | 0.00% | — | 452 | $30K |
| Sound Income Strategies, LLC | 0.00% | No change | 200 | $14K |
| Jones Financial Companies LLLP | 0.00% | Add +129.8% | 193 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +13900.0% | 140 | $9K |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 13 | $850 |
| Cassaday & Co Wealth Management LLC | 0.00% | New | 2 | $130 |
"% of holder's portfolio" is SPRB's weight in each manager's 13F, not the share of Spruce Biosciences Inc. the manager owns.